BioCentury
ARTICLE | Clinical News

Anergen regulatory update

February 14, 1994 8:00 AM UTC

The Redwood City, Calif., company received U.S. Patent No. 5,284,935 covering its AnergiX technology, which uses complexes of soluble Major Histocompatibility Complex molecules linked to antigenic pep...